The authors discovered higher levels of NGAL and MMP-9 in patients with endometrial cancer when compared to the control group of patients with healthy endometrium and benign endometrial lesions, and they concluded that the use of NGAL/MMP-9 complex may be useful in the assessment of tumor stage before the surgical treatment [145]. This evidence concerns the gene MMP9 and endometrial cancer.